Saudi Arabia
Diabetes country report 2000 — 2050
Skip Map
Number of adults (20–79 years) with diabetes in Saudi Arabia (SA)
| 2000 | 996.7 thousand |
| 2011 | 2.8 million |
| 2024 | 5.3 million |
| 2050 | 9.5 million |
Saudi Arabia is one of the 21 countries and territories in the IDF Middle-East and North Africa Region. Saudi Arabia is in the top ten countries with the highest prevalence of diabetes (20-79 years) in the world.
Data source(s) used for the diabetes estimates in adults:
- Khalid Al-Rubeaan et al. J Diabetes. 2015 Sep;7(5):622-32. doi: 10.1111/1753-0407.12224. Epub 2014 Dec 1. PMID:25266306.
- El Bcheraoui C, Basulaiman M, Tuffaha M, et al. Int J Public Health. 2014 Dec;59(6):1011-21. doi: 10.1007/s00038-014-0612-4. Epub 2014 Oct 8. PMID:25292457
2000
2011
2024
2050
Loading...
| Diabetes estimates (20-79 y) | ||||
|---|---|---|---|---|
| People with diabetes, in 1,000s | 996.7 | 2,759.6 | 5,344.6 | 9,474.0 |
| Age-standardised prevalence of diabetes, % | - | 19.6 | 23.1 | 25.4 |
| Proportion of people with undiagnosed diabetes, % | - | - | 43.6 | - |
| People with undiagnosed diabetes, in 1,000s | - | - | 2,330.2 | - |
| Impaired Fasting Glucose (IFG) | ||||
|---|---|---|---|---|
| People with IFG, in 1,000s | - | - | 3,793.1 | 5,319.6 |
| Age-standardised prevalence of IFG, % | - | - | 15.1 | 14.9 |
| Impaired Glucose Tolerance (IGT) | ||||
|---|---|---|---|---|
| People with IGT, in 1,000s | - | 177.4 | 4,085.0 | 7,039.1 |
| Age-standardised prevalence of IGT, % | - | 1.3 | 17.2 | 19.4 |
| Mortality attributable to diabetes (20-79 y) | ||||
|---|---|---|---|---|
| Deaths attributable to diabetes | - | 15,399.0 | 8,038.3 | - |
| Proportion of diabetes-related deaths in people 20-79 y, % | - | - | 14.5 | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | ||||
|---|---|---|---|---|
| Live births affected by HIP | - | - | - | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - | - | - | - |
| Live births affected by other types of diabetes first detected in pregnancy | - | - | - | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - | - | - | - |
| Diabetes-related health expenditure | ||||
|---|---|---|---|---|
| Total diabetes-related health expenditure, USD million | - | - | 7,335.5 | 10,790.3 |
| Total diabetes-related health expenditure, ID million | - | - | 17,392.3 | 25,583.4 |
| Diabetes-related health expenditure per person, USD | - | 998.0 | 1,372.5 | 1,138.9 |
| Diabetes-related health expenditure per person, ID | - | - | 3,254.2 | 2,700.4 |
| Type 1 diabetes estimates in children and adolescents | ||||
|---|---|---|---|---|
| People with type 1 diabetes (all age groups) | - | - | 222,942.0 | - |
| People with type 1 diabetes (0-19 y) | - | - | 46,468.9 | - |
| Demographics | ||||
|---|---|---|---|---|
| Total adult population (20-79 y), in 1,000s | 10,581.0 | 17,023.2 | 24,983.1 | 34,891.7 |
| Population of children and adolescents (0-19 y) | - | - | 10,525,192.0 | - |
Loading...
| Diabetes estimates (20-79 y) | |
|---|---|
| People with diabetes, in 1,000s | 996.7 |
| Age-standardised prevalence of diabetes, % | - |
| Proportion of people with undiagnosed diabetes, % | - |
| People with undiagnosed diabetes, in 1,000s | - |
| Impaired Fasting Glucose (IFG) | |
|---|---|
| People with IFG, in 1,000s | - |
| Age-standardised prevalence of IFG, % | - |
| Impaired Glucose Tolerance (IGT) | |
|---|---|
| People with IGT, in 1,000s | - |
| Age-standardised prevalence of IGT, % | - |
| Mortality attributable to diabetes (20-79 y) | |
|---|---|
| Deaths attributable to diabetes | - |
| Proportion of diabetes-related deaths in people 20-79 y, % | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | |
|---|---|
| Live births affected by HIP | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - |
| Live births affected by other types of diabetes first detected in pregnancy | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - |
| Diabetes-related health expenditure | |
|---|---|
| Total diabetes-related health expenditure, USD million | - |
| Total diabetes-related health expenditure, ID million | - |
| Diabetes-related health expenditure per person, USD | - |
| Diabetes-related health expenditure per person, ID | - |
| Type 1 diabetes estimates in children and adolescents | |
|---|---|
| People with type 1 diabetes (all age groups) | - |
| People with type 1 diabetes (0-19 y) | - |
| Demographics | |
|---|---|
| Total adult population (20-79 y), in 1,000s | 10,581.0 |
| Population of children and adolescents (0-19 y) | - |
